首页> 外国专利> Chusushinkeifukatsuzai

Chusushinkeifukatsuzai

机译:中新经济大学

摘要

PURPOSE:An agent, containing 1-methyl-4,5-dihydroorotyl-histidyl-prolinamide as an active ingredient and useful for treating central nervous disorder, e.g. disturbance of consciousness, senile dementia, etc., and hardly causing side effect. CONSTITUTION:A remedy containing 1-methyl-4,5-dihydroorotyl-histidyl- prolinamide expressed by the formula or an acid addition salt thereof as an active ingredient. The compound expressed by the formula has improved arousal promoting action and pentobarbital anesthetic antagonistic action, is capable of remarkably activating acetylcholine neuron of hypothalamus, brain stem reticular formation, brain cortex and hippocampus and suitable as a remedy for disturbance of consciousness and senile dementia and further exhibiting increasing action on conductivity and excitability of spinal movement neuron membrane and usable for treating spinocerebellar deformity. The agent has relatively less side effect (TSH releasing action, etc.) and higher safety than TRH and various derivatives thereof.
机译:用途:含有1-甲基-4,5-二氢原基-组氨酸-脯氨酰胺作为有效成分的药物,可用于治疗中枢神经疾病,例如意识障碍,老年性痴呆等,几乎不会引起副作用。组成:一种药物,该药物含有下式表示的1-甲基-4,5-二氢原基-组氨酸-脯氨酰胺或其酸加成盐作为有效成分。由该式表示的化合物具有改善的唤醒促进作用和戊巴比妥麻醉剂拮抗作用,能够显着激活下丘脑,脑干网状结构,脑皮质和海马的乙酰胆碱神经元,并且适合作为意识障碍和老年性痴呆的药物,并进一步对脊髓运动神经元膜的传导性和兴奋性具有增强作用,可用于治疗脊髓小脑畸形。与TRH及其各种衍生物相比,该试剂具有相对较小的副作用(TSH释放作用等)和更高的安全性。

著录项

  • 公开/公告号JPH0236574B2

    专利类型

  • 公开/公告日1990-08-17

    原文格式PDF

  • 申请/专利权人 TANABE SEIYAKU CO;

    申请/专利号JP19860307126

  • 申请日1986-12-22

  • 分类号A61K38/00;A61K38/04;A61P25/26;A61P25/28;

  • 国家 JP

  • 入库时间 2022-08-22 06:21:02

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号